Phibro Animal Health Corporation (NASDAQ:PAHC) Receives Average Rating of “Hold” from Analysts

Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) have been given a consensus rating of “Hold” by the seven ratings firms that are covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, two have given a hold rating, two have given a buy rating and one has issued a strong buy rating on the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $31.40.

A number of research analysts recently issued reports on PAHC shares. Weiss Ratings reiterated a “buy (b-)” rating on shares of Phibro Animal Health in a research note on Monday, December 29th. Zacks Research raised shares of Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, December 9th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Phibro Animal Health from $45.00 to $50.00 and gave the stock an “overweight” rating in a research note on Friday, November 7th.

Insiders Place Their Bets

In related news, CEO Jack Bendheim sold 13,158 shares of the company’s stock in a transaction that occurred on Thursday, January 22nd. The stock was sold at an average price of $41.98, for a total value of $552,372.84. Following the completion of the transaction, the chief executive officer directly owned 18 shares of the company’s stock, valued at $755.64. This represents a 99.86% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders sold a total of 153,400 shares of company stock worth $6,652,028 in the last three months. 50.13% of the stock is owned by insiders.

Institutional Trading of Phibro Animal Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Phibro Animal Health by 4.7% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 12,164 shares of the company’s stock valued at $260,000 after buying an additional 546 shares in the last quarter. Millennium Management LLC raised its stake in Phibro Animal Health by 74.3% during the 1st quarter. Millennium Management LLC now owns 362,030 shares of the company’s stock worth $7,733,000 after acquiring an additional 154,281 shares in the last quarter. Jane Street Group LLC lifted its position in Phibro Animal Health by 65.3% in the first quarter. Jane Street Group LLC now owns 33,917 shares of the company’s stock valued at $724,000 after acquiring an additional 13,404 shares during the last quarter. State of Alaska Department of Revenue boosted its stake in Phibro Animal Health by 7.6% in the second quarter. State of Alaska Department of Revenue now owns 12,129 shares of the company’s stock valued at $309,000 after acquiring an additional 859 shares in the last quarter. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its holdings in shares of Phibro Animal Health by 10.0% during the second quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 11,530 shares of the company’s stock worth $294,000 after purchasing an additional 1,044 shares during the last quarter. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Trading Up 1.2%

PAHC opened at $39.48 on Tuesday. The business has a fifty day moving average price of $40.05 and a 200 day moving average price of $37.63. The company has a debt-to-equity ratio of 2.32, a current ratio of 3.09 and a quick ratio of 1.35. Phibro Animal Health has a 12 month low of $16.16 and a 12 month high of $46.42. The stock has a market capitalization of $1.60 billion, a price-to-earnings ratio of 23.78, a PEG ratio of 1.10 and a beta of 0.79.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings results on Wednesday, November 5th. The company reported $0.73 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.58 by $0.15. Phibro Animal Health had a return on equity of 36.26% and a net margin of 4.85%.The company had revenue of $363.89 million for the quarter, compared to analyst estimates of $345.44 million. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. Sell-side analysts expect that Phibro Animal Health will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, December 17th. Stockholders of record on Wednesday, November 26th were given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 1.2%. The ex-dividend date of this dividend was Wednesday, November 26th. Phibro Animal Health’s dividend payout ratio (DPR) is 28.92%.

About Phibro Animal Health

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.